Business StandardCenter·
Centre puts stricter controls on sale of 4 CNS drugs over abuse concerns
Move follows expert concerns over potential misuse and intoxication; retailers will have to maintain detailed sales records for the four CNS medicines under Schedule H1
Read at Business Standard →




